|
Main | | | | | | | | | |
| Brand | Generic | Indication | MOA | Revenue | | | | |
| Medrol | | | | 242m in 2003, 260m | | | | |
| Detrol LA (tolterodine) | Incontinence | Muscarinic | 1 | 1998-2000 | Enablex, Vesicare | Oral | Teva challenging. Expires '12-19. 30MS 4/29/10. | |
| Geodon (ziprasidone) | Schizophrenia | Atypical | 1 | 2/5/2001 | Abilify, Zyprexa, Seroquel | Oral | 2012-2019 | |
| Spiriva (tiotropium) | COPD | Muscarinic | BI | 1/30/2004 | Advair | Inhaled | 2012-2023 | |
| Torisel (temsirolimus) | RCC | mTOR | 1 | 5/30/2007 | Sutent | IV | 2026 Formulation Patent | |
| Duavee (bazedoxifene) | Osteoporosis | SERM | LGND | 10/3/2013 | Premarin | Oral | NCE | |
| Viagra (sildenafil) | ED | PDE5 | 1 | 3/27/1998 | Cialis, Levitra | Oral | 3/27/2012 | |
| Xalatan (latanoprost) | Glaucoma | Prostaglandin | 1 | 6/5/1996 | Lumigan | Drops | 2010 | |
| Depo Provera: 285m | | | | | | | | |
| Inspra: 10m | | | | | | | | |
| Rescriptor (NNRTI): 80m | | | | | | | | |
| Glucotrol/XL: 175m, 221m, 257m, 281m, 284m, 298m, 332m 1997-2003 | | | | | | | | |
| Procardia XL: 1,113m, 1,005m, 822m, 699m, 460m, 311m, 220m in 1995-2001 (all Europe) | | | | | | | | |
| Tikosyn: 35m annually | | | | | | | | |
| Viracept: 530m, 530m, 436m, 365m, 337m, 258m in 1998-2002 | | | | | | | | |
| Zyrtec: 10m, 146m, 265m, 407m, 541m, 699m, 990m, 1115m, 1338m, 1287m, 1362m, 1569m, 1541m, 125m in 1995-2008 | | | | | | | | |
| Eraxis: not disclosed | | | | | | | | |
| Ponstel: 70m | | | | | | | | |
| Feldene: 40m | | | | | | | | |
| Daypro: 10m | | | | | | | | |
| Lunelle: 45m | | | | | | | | |
| Glyset: 50m | | | | | | | | |
| Healon: 105m, Corvert: 25m, Zinecard: 45m, Covera: 145m, Caverject: 10m, Provera: 60m, Salazopyrin: 65m | | | | | | | | |
| Unasyn: 370m, Mirapex: 270m, Dostinex: 225m, Fragmin: 320m, Pletil: 135m, Calan: 75m, Spiro: 75m | | | | | | | | |
| Vantin: 20m, Halcion: 60m, Dilantin: 70m, Vestra: 5m, Minipress: 30m, Lopid: 30m | | | | | | | | |
| Cefobid: 15m, Cytotec: 10m, Ansaid: 40m, Sermion: 25m, Cerebyx: 20m | | | | | | | | |
| Nipent: 5m, Somavert: 30m, Estring: 32m, Ogen: 30m, Micronase: 23m, Trelstar: 35m, Adriamycin: 55m, Pharmorubicin: 333m | | | | | | | | |
| Somavert may be larger. | | | | | | | | |
| Rapamune | | | | | | | | |
| Protonix | | | | | | | | |
| Viviant | bazedoxifene | SERM | LGND | Approved ex-US only | | | 2/28/14 Updated | |
| Embeda (morphine/naltrexone) | Pain | Morphine | 100%? | | | | | |
| Vyndaqel (tafamidis) | TTR-FAP | | 100%? | EU, CRL US 6/18/12 | ALNY | | | |
| Eraxis (anidulafungin) | Candidemia | Antifungal | 1 | 2/17/2006 | fluconazole | IV | 2012-2022 | |
| Elelyso (taliglucerase) | Gaucher's | rHP | PLX | 5/1/2012 | GENZ, SHPGY | IV | Biologic | |
| Diflucan (fluconazole) | Infections | Antifungal | 1 | 1/29/1990 | Zyvox | All | Generic? | |
| Lipitor. Approved 12/17/1996. Ranbaxy launched 11/11. | | | | | | | | |
| Camptosar. Approved 6/14/1996. | | | | | | | | |
| Norvasc. | | | | | | | | |
| Zoloft. | | | | | | | | |
| Zithromax. | | | | | | | | |
| Selzentry (maraviroc) | HIV | CCR5 | GSK | 2007 | Isentress, vicriviroc, INCB-9471 | Oral | Irrelevant | |
| Aricept (donepezil) | Alzheimer's | Cholinesterase | Eisai | 11/25/1996 | Exelon | Oral | | |
| Xiapex | Dupuytren's Contracture | Protein | AUXL US | Filed | Surgery | Injected | Biologic | Pfizer gave back? |
| Bosulif (bosutinib) | CML | ABL/SRC | 1 | | | | | |
| Troxyca ER (ALO-02) | Pain | Oxycodone+Naltrexone | 1 | III | | | 2/28/14 Updated | |
| Steglatro (ertugliflozin), fka PF-04971729 | Type 2 Diabetes | SGLT2 | MRK | III | | Oral | 2/28/14 Updated | |
| rivipansel GMI-1070/PF-06460031 | Vaso Occlusive Crisis | Undisclosed | 1 | II | | | 2/28/14 Updated | |
| Effexor XR (venlafaxine) | Depression | SNRI | 1 | 10/20/1997 | Oral | | Divested to VTRS | |